Founders Grove Wealth Partners’s Eli Lilly LLY Stock Holding History

Founders Grove Wealth Partners’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$18.4M	Sell	15,366 -2,004	-12%	-$2.05M	3.68%	5
2026 Q1	$16M	Sell	17,370 -44	-0.3%	-$44.6K	3.63%	5
2025 Q4	$18.7M	Sell	17,414 -3,956	-19%	-$3.78M	4.21%	5
2025 Q3	$16.3M	Sell	21,370 -90	-0.4%	-$67K	3.83%	5
2025 Q2	$16.7M	Buy	21,460 +61	+0.3%	+$47.4K	4.2%	5
2025 Q1	$17.7M	Sell	21,399 -955	-4%	-$795K	4.92%	3
2024 Q4	$17.3M	Buy	+22,354	New	+$18.5M	5%	4

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Founders Grove Wealth Partners's LLY Position: Q2 2026 in Review

Founders Grove Wealth Partners reduced its Eli Lilly (LLY) stake by 12% in Q2 2026, selling an estimated $2.05M and leaving 15,366 shares worth $18.4M. The position accounts for 3.68% of the portfolio, ranked #5.

Founders Grove Wealth Partners first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. The position peaked at $18.7M in Q4 2025. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Founders Grove Wealth Partners held 15,366 shares of Eli Lilly worth $18.4M as of Q2 2026.
Founders Grove Wealth Partners sold 2,004 Eli Lilly shares in Q2 2026, an estimated $2.05M.
Eli Lilly made up 3.68% of Founders Grove Wealth Partners's portfolio in Q2 2026, its #5 holding.
Founders Grove Wealth Partners first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
Founders Grove Wealth Partners's Eli Lilly position peaked at $18.7M in Q4 2025.
4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Founders Grove Wealth Partners's 13F filing for Q2 2026, filed 22 Jul 2026.